艾斯基他胺对接受选择性手术的全身麻醉患者的术后妄想的影响:随机对照试验的元分析
Wenhui Zhang1,2, Di Wang1,3, Siru Li1,3
1Department of Anesthesiology, Central Hospital of Dalian University of Technology, No. 826 Southwest Road, Shahekou District, Dalian, Liaoning Province, China.
石胺显著降低了在接受全身麻醉的患者中术后妄想的发生率. 这次元分析没有发现不良反应的增加,这表明胺是预防狂妄症的安全选择.
科学领域:
- 麻醉学 麻醉学
- 神经科学是一个神经科学.
- 关键护理医学 关键护理医学
背景情况:
- 手术后痴呆症 (POD) 是老年手术患者的常见并发症,与不良结果有关.
- 确定有效的干预措施来预防POD对于改善患者预后至关重要.
研究的目的:
- 为了评估胺在降低术后狂妄症的发生率方面的疗效.
- 评估埃斯基坦胺关于不良事件的安全概况.
主要方法:
- 对随机对照试验 (RCT) 进行了系统的元分析.
- 搜索的数据库包括PubMed,Embase,Cochrane图书馆和CNKI,截至2024年4月21日.
- 用RevMan5.4软件分析了数据,并计算了风险比率和平均差异.
主要成果:
- 素显著降低了手术后狂妄症的发生率 (RR:0.43;95% CI:0.330.57).
- 与对照组相比,没有观察到不良事件 (恶心,吐,头,呼吸抑制) 的显著差异.
- 石胺使用与低血压的发病率较低 (RR:0.24;95% CI:0.120.48) 和手术后24小时减少疼痛评分有关.
结论:
- 在全身麻醉期间诱导esketamine有效地减少了手术后妄想的发生率.
- 胺似乎是一种安全的麻醉剂,不会增加常见副作用的风险.
更多相关视频
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
相关概念视频
Depolarizing Blockers: Pharmocokinetics
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia
Parenteral Anesthetics: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
